Uncategorized
Eleven Biotherapeutics reports net loss of $6.5 million in first quarter
Eleven Biotherapeutics reported a net loss applicable to common stockholders of $6.5 million, or $0.36 per share, in the first quarter of 2015, compared with a net loss of $7.7 million, or $0.80 per share, in the first quarter of 2014, according to a press release. Total revenue was reported at $0.2 million in the first quarter compared with $0.6 million in the same quarter a year ago.